US 8,067,571

Application 11/803,107 · Granted Nov 29, 2011

Antibacterial antisense oligonucleotide and method

Estimated expiration

December 21, 2026

29 days remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jul 13, 2006
+ 20 years
Jul 13, 2026
PTA +161d
Dec 21, 2026
TD applied
Dec 21, 2026
Final
Dec 21, 2026

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
May 11, 2007
Earliest effective filing
July 13, 2006
Issue date
November 29, 2011
PTA
+161 days
Base expiry (before PTA)
July 13, 2026

July 13, 2006 + 20 years = July 13, 2026 + 161 PTA days = December 21, 2026

  • Continuation-in-part of application 11/487,009, filed Jul 13, 2006, issued as US 7,790,694
  • PRO60/699,280 — Provisional — not used for base term
  • PRO60/699,280 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to December 21, 2026

  • US 7,625,873· Application 11/432,216Lapsed

    Antisense antibacterial method and compound

    Expired: maintenance fee lapse.

    Filing date
    May 10, 2006
    Earliest effective filing
    May 10, 2006
    Issue date
    Dec 1, 2009
    PTA
    0 days
    Calculated expiration
    —
  • US 8,067,571· Application 11/803,107(from application 11/803,107)Capping patent

    Antibacterial antisense oligonucleotide and method

    Filing date
    May 11, 2007
    Earliest effective filing
    Jul 13, 2006
    Issue date
    Nov 29, 2011
    PTA
    +161 days
    Calculated expiration
    Dec 21, 2026

    Continuation-in-part of 11/487,009, filed Jul 13, 2006, issued as US 7,790,694

    Jul 13, 2006 + 20y + 161d PTA = Dec 21, 2026

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 11/803,107 · US 8,067,571

PatentReply compiles the prosecution history behind US 8,067,571: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8067571

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.